BROADCASTS.com

b'

Ready to peel back the layers of the medical universe and step into the world of renal cancer? We've got your ticket right here! Joined by\\xa0 urological surgeon, Dr Mark Lloyd, we journey into the intricacies of renal cancer.

In a riveting discussion with our host Dr Gavin Nimon (Adelaide Orthopaedic Surgeon), Dr Lloyd unveils the subgroups of renal cancer, the genetic marvel of the von Hippel Lindau gene, and\\xa0 targeted treatment, such as Sunitinib.\\xa0 Further, we familiarize ourselves with the TNM staging system, a crucial tool in determining the most beneficial treatment method for the patient.

As we dissect the treatment landscape for renal carcinoma, we encounter robotic surgery, whose precision goes beyond the grasp of the human hand. We tackle minimally invasive techniques like laparoscopic nephrectomy and robotic partial nephrectomy, used widely for treating renal tumors. Weighing in on focal therapy, an alternative route to surgical intervention, we discuss its effectiveness in small renal tumors and the types of tumors suitable for thermal treatments.\\xa0 So gear up for a roller coaster ride through the world of renal cancer!

Aussie Med Ed is sponsored by Tego - Medical Indemnity Insurance and Healthshare .
Tego offer medical indemnity insurance for specialists underwritten by Berkshire Hathaway. 
HealthShare is a digital health company that provides solutions for patients, GPs and Specialists across Australia.